Graig Suvannavejh
Stock Analyst at Mizuho
(2.41)
# 2,415
Out of 4,732 analysts
143
Total ratings
47.71%
Success rate
-2.81%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Graig Suvannavejh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXSM Axsome Therapeutics | Maintains: Outperform | $124 → $122 | $91.94 | +32.70% | 17 | Dec 31, 2024 | |
| ADAP Adaptimmune Therapeutics | Maintains: Outperform | $3 → $1.5 | $0.58 | +158.67% | 2 | Nov 27, 2024 | |
| AUTL Autolus Therapeutics | Upgrades: Buy | $7 → $7.6 | $2.22 | +242.34% | 1 | Nov 18, 2024 | |
| IMCR Immunocore Holdings | Downgrades: Neutral | $72 → $38 | $29.02 | +30.94% | 7 | Nov 11, 2024 | |
| APLS Apellis Pharmaceuticals | Maintains: Neutral | $39 → $38 | $29.94 | +26.94% | 6 | Oct 24, 2024 | |
| HRMY Harmony Biosciences Holdings | Maintains: Outperform | $42 → $52 | $39.05 | +33.16% | 15 | Oct 10, 2024 | |
| CRBP Corbus Pharmaceuticals Holdings | Reiterates: Outperform | $74 | $11.92 | +520.81% | 1 | Sep 20, 2024 | |
| ATHA Athira Pharma | Downgrades: Neutral | $5 → $0.5 | $0.53 | -5.73% | 3 | Sep 19, 2024 | |
| HALO Halozyme Therapeutics | Maintains: Neutral | $44 → $49 | $54.80 | -10.58% | 6 | Jul 22, 2024 | |
| IDYA IDEAYA Biosciences | Initiates: Outperform | $50 | $22.18 | +125.43% | 1 | Jul 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $2.05 | +875.61% | 1 | Jul 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $96 → $100 | $126.20 | -20.76% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $82 | $72.51 | +13.09% | 6 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $5.35 | +199.07% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $3 | $3.60 | -16.67% | 5 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $39 → $30 | $7.48 | +301.07% | 4 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $22 | $4.33 | +408.08% | 4 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $8 | $2.02 | +296.04% | 1 | Apr 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 | $5.01 | -30.14% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $10 | $4.43 | +125.73% | 5 | Nov 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $9 | $1.71 | +426.32% | 4 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $4 | $0.34 | +1,062.79% | 8 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $1 | $4.12 | -75.74% | 5 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.93 | +677.20% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $35 | $54.54 | -35.83% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $8 | $7.17 | +11.58% | 6 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $71 → $57 | $45.74 | +24.62% | 2 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $8 → $5 | $29.55 | -83.08% | 4 | Apr 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $34 | $4.37 | +678.03% | 1 | Jun 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $28 | $5.06 | +453.36% | 1 | Apr 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $31 | $26.26 | +18.05% | 1 | Apr 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $19 | $1.33 | +1,328.57% | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $4.75 | $1.69 | +181.07% | 1 | Nov 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $36 | $12.68 | +183.91% | 2 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $23.76 | - | 1 | Oct 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $37 | $1.05 | +3,423.81% | 1 | Oct 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $128 | $121.18 | +5.63% | 1 | Sep 14, 2020 |
Axsome Therapeutics
Dec 31, 2024
Maintains: Outperform
Price Target: $124 → $122
Current: $91.94
Upside: +32.70%
Adaptimmune Therapeutics
Nov 27, 2024
Maintains: Outperform
Price Target: $3 → $1.5
Current: $0.58
Upside: +158.67%
Autolus Therapeutics
Nov 18, 2024
Upgrades: Buy
Price Target: $7 → $7.6
Current: $2.22
Upside: +242.34%
Immunocore Holdings
Nov 11, 2024
Downgrades: Neutral
Price Target: $72 → $38
Current: $29.02
Upside: +30.94%
Apellis Pharmaceuticals
Oct 24, 2024
Maintains: Neutral
Price Target: $39 → $38
Current: $29.94
Upside: +26.94%
Harmony Biosciences Holdings
Oct 10, 2024
Maintains: Outperform
Price Target: $42 → $52
Current: $39.05
Upside: +33.16%
Corbus Pharmaceuticals Holdings
Sep 20, 2024
Reiterates: Outperform
Price Target: $74
Current: $11.92
Upside: +520.81%
Athira Pharma
Sep 19, 2024
Downgrades: Neutral
Price Target: $5 → $0.5
Current: $0.53
Upside: -5.73%
Halozyme Therapeutics
Jul 22, 2024
Maintains: Neutral
Price Target: $44 → $49
Current: $54.80
Upside: -10.58%
IDEAYA Biosciences
Jul 8, 2024
Initiates: Outperform
Price Target: $50
Current: $22.18
Upside: +125.43%
Jul 8, 2024
Initiates: Outperform
Price Target: $20
Current: $2.05
Upside: +875.61%
Jun 21, 2024
Maintains: Buy
Price Target: $96 → $100
Current: $126.20
Upside: -20.76%
Jun 7, 2024
Maintains: Buy
Price Target: $36 → $82
Current: $72.51
Upside: +13.09%
May 16, 2024
Maintains: Buy
Price Target: $14 → $16
Current: $5.35
Upside: +199.07%
May 14, 2024
Maintains: Neutral
Price Target: $4 → $3
Current: $3.60
Upside: -16.67%
May 7, 2024
Maintains: Buy
Price Target: $39 → $30
Current: $7.48
Upside: +301.07%
Apr 29, 2024
Maintains: Buy
Price Target: $40 → $22
Current: $4.33
Upside: +408.08%
Apr 2, 2024
Maintains: Buy
Price Target: $20 → $8
Current: $2.02
Upside: +296.04%
Mar 27, 2024
Maintains: Neutral
Price Target: $3.5
Current: $5.01
Upside: -30.14%
Nov 27, 2023
Maintains: Buy
Price Target: $17 → $10
Current: $4.43
Upside: +125.73%
Nov 17, 2023
Maintains: Buy
Price Target: $10 → $9
Current: $1.71
Upside: +426.32%
Aug 23, 2023
Reiterates: Neutral
Price Target: $4
Current: $0.34
Upside: +1,062.79%
Jun 5, 2023
Downgrades: Neutral
Price Target: $17 → $1
Current: $4.12
Upside: -75.74%
Mar 31, 2023
Initiates: Buy
Price Target: $15
Current: $1.93
Upside: +677.20%
Nov 10, 2022
Maintains: Buy
Price Target: $31 → $35
Current: $54.54
Upside: -35.83%
Nov 10, 2022
Maintains: Neutral
Price Target: $9 → $8
Current: $7.17
Upside: +11.58%
May 24, 2022
Maintains: Buy
Price Target: $71 → $57
Current: $45.74
Upside: +24.62%
Apr 19, 2022
Maintains: Sell
Price Target: $8 → $5
Current: $29.55
Upside: -83.08%
Jun 1, 2021
Initiates: Buy
Price Target: $34
Current: $4.37
Upside: +678.03%
Apr 20, 2021
Initiates: Neutral
Price Target: $28
Current: $5.06
Upside: +453.36%
Apr 19, 2021
Initiates: Neutral
Price Target: $31
Current: $26.26
Upside: +18.05%
Mar 2, 2021
Initiates: Sell
Price Target: $19
Current: $1.33
Upside: +1,328.57%
Nov 24, 2020
Initiates: Neutral
Price Target: $4.75
Current: $1.69
Upside: +181.07%
Nov 9, 2020
Upgrades: Buy
Price Target: $36
Current: $12.68
Upside: +183.91%
Oct 21, 2020
Downgrades: Sell
Price Target: n/a
Current: $23.76
Upside: -
Oct 20, 2020
Initiates: Neutral
Price Target: $37
Current: $1.05
Upside: +3,423.81%
Sep 14, 2020
Downgrades: Sell
Price Target: $128
Current: $121.18
Upside: +5.63%